Filing Details

Accession Number:
0001415889-24-016100
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-07 21:40:12
Reporting Period:
2024-05-29
Accepted Time:
2024-06-07 21:40:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1231457 Genelux Corp GNLX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1937573 Thomas Zindrick C/O Genelux Corporation
2625 Townsgate Road, Suite 230
Westlake Village CA 91361
President And Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-05-29 200,000 $0.00 200,000 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrant (Right to Buy) Acquisiton 2024-05-29 200,000 $0.00 200,000 $5.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
200,000 2024-05-29 2029-05-29 No 4 P Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 14,651 Direct
Footnotes
  1. The reported securities consist of shares of common stock sold together with accompanying warrants to purchase common stock. The combined price of each share of common stock offered together with one warrant was $4.00.
  2. By Zindrick Living Trust DTD 3-5-2009